2-Methoxyestradiol - AmradAlternative Names: 2-ME - Amrad; 2-ME2 - Amrad
Latest Information Update: 05 Mar 2003
At a glance
- Originator Zenyth Therapeutics
- Class Antineoplastics; Estradiol congeners; Estrenes; Small molecules
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 05 Mar 2003 No development reported - Preclinical for Asthma in Australia (unspecified route)
- 31 Dec 1998 Preclinical trials in Asthma in Australia (unspecified route)